Eton Pharmaceuticals (ETON) Total Current Liabilities (2017 - 2025)

Eton Pharmaceuticals has disclosed Total Current Liabilities across 9 years of filings, most recently posting $38.5 million for Q4 2025.

• Total Current Liabilities for Q4 2025 came in at $38.5 million, up 92.96% year-over-year; the trailing twelve-month figure through Dec 2025 was $38.5 million (up 92.96% YoY), and the FY2025 annual result was $38.5 million, up 92.96% from the prior year.
• Total Current Liabilities came in at $38.5 million for Q4 2025 at Eton Pharmaceuticals, down from $44.2 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $44.2 million in Q3 2025 to a low of $3.1 million in Q2 2021.
• The 5-year median for Total Current Liabilities is $10.0 million (2023), against an average of $14.9 million.
• Across the five-year window, Total Current Liabilities retreated 13.04% in 2022 and soared 151.52% in 2023, its largest moves.
• Eton Pharmaceuticals' Total Current Liabilities stood at $4.6 million in 2021, then soared by 41.75% to $6.5 million in 2022, then jumped by 151.37% to $16.2 million in 2023, then increased by 22.82% to $19.9 million in 2024, then jumped by 92.96% to $38.5 million in 2025.
• The last three Total Current Liabilities figures came in at $38.5 million (Q4 2025), $44.2 million (Q3 2025), and $38.6 million (Q2 2025), per Business Quant data.